Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andrew Wisniewski"'
Autor:
Claudine Desruisseaux, Michaël Bensoussan, Etienne Désilets, Hanh-Khiem Tran, Robert Arcand, Germain Poirier, Andrew Wisniewski, Thibaut Manière
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Collagenous sprue (CS) is a distinct clinicopathological disorder histologically defined by a thickened subepithelial band (Freeman, 2011). It is a rare condition which has been recently observed in a significant proportion of sprue-like enteropathy
Externí odkaz:
https://doaj.org/article/ca80c1346db046ceaf84b3605ba7feae
Publikováno v:
Athletic Training & Sports Health Care. 8:8-16
BACKGROUND Crohn's disease (CD) is a chronic, disabling and destructive condition. Half of patients will develop some bowel damage (stricture, fistula and/or abscess). Current therapeutic strategies failed to alter its natural history. OBJECTIVE We e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783a9ee27020e47d03259c831dfb2c69
Autor:
Andrew Wisniewski, Magali Svrcek, Laurent Beaugerie, Laurent Siproudhis, Laurent Abramowitz, Jean-François Fléjou
Publikováno v:
Journal of Crohn'scolitis. 11(8)
Patients with inflammatory bowel disease [IBD] may develop, similarly to individuals from general population, rare cases of human papilloma virus [HPV]-related anal canal squamous cell carcinoma [SCC] and intra-epithelial precursor lesions, as well a
Autor:
Kevin Perez, Isabelle Nion-Larmurier, Laurent Beaugerie, P. Marteau, Andrew Wisniewski, Anne Bourrier, P. Seksik, Cécilia Landman, Jacques Cosnes, Harry Sokol
Publikováno v:
Alimentary Pharmacology and Therapeutics
Alimentary Pharmacology and Therapeutics, Wiley, 2016, 44 (10), pp.1102-1113. ⟨10.1111/apt.13808⟩
Alimentary Pharmacology and Therapeutics, 2016, 44 (10), pp.1102-1113. ⟨10.1111/apt.13808⟩
Alimentary Pharmacology and Therapeutics, Wiley, 2016, 44 (10), pp.1102-1113. ⟨10.1111/apt.13808⟩
Alimentary Pharmacology and Therapeutics, 2016, 44 (10), pp.1102-1113. ⟨10.1111/apt.13808⟩
International audience; Background: The comparative efficacy of adalimumab (ADA) and infliximab (IFX) in Crohn's disease, and the benefit of initial combotherapy with an immunomodulator, are debated.Aim: To assess the best anti-TNF treatment regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8420499e9977693a0836b806043ce8c
https://hal.sorbonne-universite.fr/hal-01421061
https://hal.sorbonne-universite.fr/hal-01421061
Autor:
Jacques Cosnes, Anne Bourrier, Isabelle Nion-Larmurier, Cécilia Landman, Julien Kirchgesner, Philippe Seksik, Laurent Beaugerie, Andrew Wisniewski, Harry Sokol
Publikováno v:
Gastroenterology. 150:S225